geko.health

Resources

Hospital Application

Oedema Reduction

Neuromuscular Electro-Stimulation as Adjunct Therapy for Chronic Leg Lymphedema and Lipoedema

Author(s): Yolandi Fourie

The use of the geko™ device and the activation of the foot and calf pumps for prevention of venous thromboembolism in patients with acute stroke

Author(s): Natarajan I, Williams J, Richards, L, Moss C, Lambert C, Roffe C

Scarf Osteotomy

Author(s): Pillai A

Cheilectomy for Hallux Rigidus Repair

Author(s): Pillai A

Hindfoot Fusion

Author(s): McKinley J, Walker S, Wainwright T W

The role of geko™, a portable electrical stimulation device, in the treatment of longstanding unilateral leg lymphedema

Author(s): Hill W, Ramage D

Using the geko™ device to increase blood flow and prevent oedema following lower limb reconstruction by the Ilizarov method

Author(s): Shalaby H, Walker S

Two Cases of Transcutaneous Electrical Nerve Stimulation of the Common Peroneal Nerve Successfully Treating Refractory, Multifactorial Leg Edema.

Author(s): Ingves M V, Power A H

Case study series: Using the geko™ device to prevent oedema and promote functional activity following foot surgery

Author(s): Pillai A, Pavey N, Wainwright T W

Using the geko™ device to prevent oedema following ankle replacement surgery

Author(s): McKinley J, Walker S, Wainwright T W

Preventions of Venous Thromboembolism

Pilot Trial of Neuromuscular Stimulation in Human Subjects with Chronic Venous Disease

Author(s): Williams K J, Moore H M, Ellis M, Davies A H

Introduction of the geko™ device at North Bristol Trust UK

Author(s): Hitchcock K, Austin L

Further update on the role of geko™ in reducing the risk of venous thromboembolism (VTE) in Obstetrics

Author(s): M. Andrzejowska, B Godwin, M Fawzy

Prediction and prophylaxis of postoperative thromboembolis—a comparison between peroperative calf muscle stimulation with groups of impulses and dextran 40

Author(s): Lindström B, Holmdahl C, Jonsson O, Korsan‐Bengtsen K, Lindberg S, Petrusson B, Pettersson S, Wikstrand J, Wojciechowski J

Prophylaxis of postoperative leg vein thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial.

Author(s): Rosenberg I L , Evans M, Pollock A V

The use of the geko™ device for the prevention of venous thromboembolism in patients with acute stroke at The Luton & Dunstable University Hospital (L&D)

Author(s): Nihara D, Sethuraman S, Sekaran L, Phiri D, Asokanathan A, Alwis L

Clinical observation of neuromuscular electrical stimulation in prevention of deep venous thrombosis after total hip replacement

Author(s): Jingwei L, Zhe Z, Xuesong L, Hui J, Ning L, Wenbo W

The role of the geko™ device to prevent Deep Vein Thrombosis (DVT) on a patient undergoing rehabilitation on the gastro-intestinal ward

Author(s): Wong C

geko™ device – Product Evaluation and Welsh Supply Chain Logistics – An Innovation case study

Author(s): Welsh Case Study

Acute Stroke Hospitalization and Deep Vein Thrombosis Prophylaxis: Gaps in Care and the Unmet Need

Author(s): Hairston M, Renati S, Platti N, Rose DZ

Wound Therapy Application

The geko™ device is a transformative innovation in healthcare. Beyond improving patient outcomes, the geko™ device offers substantial cost savings in primary care settings.

This small, self-adhesive wearable utilizes neuromuscular electro-stimulation (NMES), applied to the skin just below the knee, targeting the common peroneal nerve. Delivering gentle intermittent electrical pulses at a rate of once per second, it triggers muscular twitches that activate venous muscle pumps in the leg and foot. This activation boosts venous, arterial, and microvascular blood flow, facilitating the transport of oxygenated blood to the wound site and periphery, thereby enhancing wound healing.

Healing Rate and Time to Closure of Venous Leg Ulcers: A Real-World Service Evaluation of Neuromuscular Electrostimulation as an Adjunct to Compression Therapy

Key Findings:
The geko device group showed a significantly improved healing rate of 0.56 mm per week compared to 0.31 mm in the control group. Additionally, the average time to wound closure was reduced from 77 days to just 40 days with the use of the geko device.

Author(s): Holly Murray, BNSc, RN, WOCN, NSWOC, WOCC(C), Rochelle Duong, MHA, BScN, RN, and Duncan Shirreffs Bain, PhD

Neuromuscular Electro-Stimulation as Adjunct Therapy for Chronic Leg Lymphedema and Lipoedema

Author(s): Yolandi Fourie

Debilitating chronic veno-lymphoedema: using a muscle pump activator medical device to heal wounds and improve skin integrity

Author(s): Harris C, Rabley-Koch C A, Ramage D, Cattryse R

The Implementation of a novel NMES device into a community home care program

Author(s): Coppola L

The Effect of NMES on Venous Leg Ulcers and a Pressure Ulcer Author(s): Charlebois A Poster

Author(s): Charlebois A

Lessons Learned – The Implementation of a novel NMES Device

Author(s): Springer D A

A role for a portable NMES device for treatment of refractory chronic wounds of the lower extremity

Author(s): Wong V

A NMES device, not just for routine wound care

Author(s): Flett N

The geko™ a neuromuscular electrostimulation (NMES) device and its healing effect on diabetic foot and venous leg ulcers

Author(s): Brooke J, Loney A

Evaluation of an Exciting Neuromuscular Electrostimulation Device for Chronic, Non-healing Venous Leg Ulcers

Author(s): Harris C, Duong R, Van der Heyden G, Byrnes B, Cattryse R, Orr A, Keast D

Case Studies

Activation of the Venous Muscle Pump by Neuromuscular Stimulation of the Common Peroneal Nerve Reduces Postoperative Edema in the Foot and Ankle.
Healing Rate and Time to Closure of Venous Leg Ulcers: A Real-World Service Evaluation of Neuromuscular Electrostimulation as an Adjunct to Compression Therapy
A prospective study to determine the safety of the geko® neuromuscular electrostimulation device in a pacemaker population.